FSTL3 and non-small cell lung carcinoma: Moreover, Gao et al. have pinpointed that FSTL3 is a brand new oncogene of non-small cell lung cancer (NSCLC), and FSTL3 inhibition impedes NSCLC development, migration, and invasion [18].